European Companies Search Engine
UK funding (£132,247): Combining CRISPR screens and AI to Identify Novel Therapeutic Strategies to Target Cancer Stroma Interactions Ukri1 Oct 2024 UK Research and Innovation, United Kingdom
Overview
Text
Combining CRISPR screens and AI to Identify Novel Therapeutic Strategies to Target Cancer Stroma Interactions
| Abstract | Doctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only. |
| Category | Training Grant |
| Reference | BB/Z516867/1 |
| Status | Active |
| Funded period start | 01/10/2024 |
| Funded period end | 30/09/2028 |
| Funded value | £132,247.00 |
| Source | https://gtr.ukri.org/projects?ref=BB%2FZ516867%2F1 |
Participating Organisations
| Queen Mary University of London | |
| Exscientia Limited |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Queen Mary University of London, London.
The visualizations for "Queen Mary University of London - UK funding (£132,247): Combining CRISPR screens and AI to Identify Novel Therapeutic Strategies to Target Cancer Stroma Interactions"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
